Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Management of Chemotherapy-Induced Nausea and Vomiting (CINV)
EP. 1: Challenges in the Treatment of CINV
July 17th 2017
EP. 2: Types of CINV
July 17th 2017
EP. 3: Classification of Emetogenicity of Chemotherapeutic Agents
July 17th 2017
EP. 4: Multidisciplinary Approach to Treating CINV
July 17th 2017
EP. 5: Patient Risk Factors in CINV
July 17th 2017
EP. 6: Patient Education Materials for CINV
July 17th 2017
EP. 7: Treating CINV Due to Immunotherapy and Targeted Therapy
July 17th 2017
EP. 8: Role of 5-HT3 Receptor Antagonists in Treating CINV
July 17th 2017
EP. 9: Role of NK1 Receptor Antagonists in Treating CINV
July 17th 2017
EP. 10: 5-HT3/NK1 Receptor Antagonist Combinations for CINV
July 17th 2017
EP. 11: Use of Olanzapine in CINV
July 17th 2017
EP. 12: Use of Dexamethasone in CINV
July 17th 2017
EP. 13: Unmet Needs in CINV
July 17th 2017
x
